House passes 'right to try' drug bill The House passed “right to try” legislation on experimental drugs largely along party lines Wednesday, sending a bill backed by President Trump to the Senate. Last week, House Republican leaders put the bill on the floor under suspension of the rules. Democrats objected, expressing safety concerns over how the measure would bypass the Food and Drug Administration (FDA), and it fell short of the necessary two-thirds support it needed. Read More March 22, 2018 legislation, Public Health 0 0 Comment Read More »
The Other Opioid Crisis: Hospital Shortages Lead To Patient Pain, Medical Errors Even as opioids flood American communities and fuel widespread addiction, hospitals are facing a dangerous shortage of the powerful painkillers needed by patients in acute pain, according to doctors, pharmacists and a coalition of health groups. Read More... March 19, 2018 Public Health 0 0 Comment Read More »
Villaraigosa is right, single-payer healthcare in California is a political pipe dream Antonio Villaraigosa thinks he has a solid weapon to hammer Lt. Gov. Gavin Newsom with as they run for governor. And he probably does. It's Newsom's strong support for creating a state-run, single-payer health insurance program. Read More... March 13, 2018 General, Medicare, Public Health 0 0 Comment Read More »
How Long Are You Contagious With The Flu? It's shaping up to be one of the worst flu seasons in years. If you are one of the thousands of Americans who are sick with the flu, this one's for you. You've spent the past couple of days cooped up in your house watching bad TV, fighting the fever sweats and expelling a baffling amount of mucus. As you start to resemble a human being again, you might feel pressure to head back to work. But when is it really OK to return? Many people go back as soon as their ... February 21, 2018 Public Health 0 0 Comment Read More »
Whistleblowers: DEA attorneys went easy on McKesson, the country's largest drug distributor In 2014, after two years of painstaking inquiry by nine DEA field divisions and 12 U.S. Attorneys, investigators built a powerful case against McKesson for the company's role in the opioid crisis. Read More... January 4, 2018 DEA, McKesson, Public Health 0 0 Comment Read More »
